title: Gemcitabine-induced radiation recall myositis in a patient with dermatomyositis.
authors.affiliation: Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia 5000, Australia.
authors.forename: Scott W
authors.initials: SW
authors.lastname: Graf
authors.forename: Vidya S
authors.initials: VS
authors.lastname: Limaye
authors.forename: Leslie G
authors.initials: LG
authors.lastname: Cleland
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D000077192:Adenocarcinoma of Lung; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001005:Anus Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003882:Dermatomyositis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D009220:Myositis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D009378:Neoplasms, Multiple Primary; D011832:Radiation Injuries / Q000139:chemically induced* / Q000175:diagnosis; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D007166:Immunosuppressive Agents; D003841:Deoxycytidine; D000093542:Gemcitabine